Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.02.29
2019年度业绩快报
2020.02.28
2020年面向及格投资者果真刊行公司债券(疫情防控债)刊行效果通告
2020.02.28
2020年第一次暂时股东大会决议通告
2020.02.28
2020年第一次暂时股东大会的执法意见书
2020.02.28
第四届董事会第三十次聚会决议通告
2020.02.26
2020年面向及格投资者果真刊行公司债券(疫情防控债)票面利率通告
2020.02.26
2020年面向及格投资者果真刊行公司债券(疫情防控债)刊行相关情形的调解通告
2020.02.26
2020年面向及格投资者果真刊行公司债券(疫情防控债)刊行相关情形的调解通告
2020.02.25
2020年果真刊行公司债券信用评级报告
2020.02.25
2020年面向及格投资者果真刊行公司债券(疫情防控债)更名通告
第一页
上一页
34
35
36
37
38
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】